湘佳股份(002982.SZ)擬1.2億元投建科研智慧大樓項目(一期)
格隆匯5月18日丨湘佳股份(002982.SZ)公佈,公司於2020年5月18日召開公司第三屆董事會第二十一次會議,審議通過了《關於投資建設科研智慧大樓項目(一期)的議案》,該議案尚需提交股東大會審議。
項目名稱:科研智慧大樓項目(一期);湘佳總部食品研發樓、檢測中心、公寓樓、智慧辦公樓等。同時包括相關檢驗檢測設備的購置。此外還包括項目區內道路及場地硬化、給排水、供配電、綠化、消防等配套工程的建設。項目建設期為24個月。項目估算總投資1.2億元,資金來源為企業自籌。
此次投資是為滿足公司在食品研發、綜合檢測能力的提升,改善集團智慧辦公、人才引進條件,適應公司戰略實施和穩健發展的需要。該項目的實施將提升公司食品研發、食品檢測的能力,提高辦公效率、提升公司的形象,對公司發展壯大有着積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.